30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Ber Gerard

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 10% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Ber Gerard's trades of Y-mAbs Therapeutics, Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-03 2024-09-03
PrS Proposed sale
72,521
337.95
US$4,677,929 		72,521 337.95 US$4,677,929
2024-08-14 2024-08-12
PlS Planned sale
246 -31.2%
465.21
US$3,723,485 		246 -31.2% 465.21 US$3,723,485
2024-08-14 2024-08-12
PlS Planned sale
37,394 -11.3%
205.34
US$4,394,371 		37,394 -11.3% 205.34 US$4,394,371
2024-08-14 2024-08-12
PlS Planned sale
11,175 -30.4%
96.23
US$1,075,370 		11,175 -30.4% 96.23 US$1,075,370
2024-08-12 2024-08-12
PrS Proposed sale
15,500
97.33
US$1,508,615 		15,500 97.33 US$1,508,615
2024-06-11 2024-06-10
S Sale
722 -31.0%
12.00
US$8,664 		722 -31.0% 12.00 US$8,664
2024-06-10 2024-06-10
PrS Proposed sale
722
12.00
US$8,665 		722 12.00 US$8,665
2022-05-12 2022-05-10
S Sale
1,277 -3.8%
58.19
US$74,309 		1,277 -3.8% 58.19 US$74,309